
The A2 Milk Company Ltd (ASX: A2M) share price has started the week positively.
In afternoon trade, the infant formula companyâs shares are up 1.5% to $5.50.
This means the A2 Milk share price is now up 5% since this time last week.
Why is the A2 Milk share price rising?
Investors have been buying the companyâs shares since last weekâs announcement of US FDA approval to import its infant formula into the enormous market.
According to the announcement, the FDA has approved the import, sale, and distribution of a2 Platinum infant formula products (Stages 1 and 2) from New Zealand through to 3 January 2023. This can be extended through to October 2025 at the FDAâs discretion.
A2 Milk was granted approval after changing its product design to meet the US FDAâs requirements. This will see the products manufactured with different scoops, mixing instructions, and labelling.
Broker reaction
The team at Bell Potter reacted positively to the news. In response, the broker retained its buy rating and lifted its price target slightly to $6.80. This implies potential upside of almost 24% for investors over the next 12 months.
Bell Potter was pleased with the news. Though, it acknowledges that that the gross margin on these products is expected to be lower. As a result, it has only modestly increased its earnings estimates for the coming years.
A2M expects US gross margins to be lower than average, distribution costs to be higher (initially air freighted), some rework costs, and incremental marketing and trade investment to enter the category. The prevalence of slotting fees, tariffs (once a certain import quota has been met) and higher marketing (as a proportion of sales) in our view are likely to result in more modest margins than those generated in Australian IMF channels.
We have adjusted our forecasts to incorporate modest sales volumes in the US IMF category through to FY25e (assuming sustained market access) and also updated for 1H23 NZD movements. The net effect is NPAT upgrades of +2% in FY23e, +1% in FY24e and +3% in FY25e.
Nevertheless, the broker believes the US business could eventually become a meaningful contributor to its earnings. It concludes:
We view the initial entry into the US IMF category as incrementally positive, though note the scale of A2Mâs existing US fresh distribution footprint implies this could be a more meaningful contributor should sales velocities approach levels seen in other markets.
The post Broker tips A2 Milk share price to jump 24% appeared first on The Motley Fool Australia.
Tech Stock Thatâs Changing Streaming
Streaming TV Shocker: One stock we think could set to profit as people ditch free-to-air for streaming TV (Hint It’s not Netflix, Disney+, or even Amazon Prime)
Learn more about our Tripledown report
*Returns as of November 1 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Why did the A2 Milk share price go backwards in October?
- Brokers name 3 ASX shares to buy today
- Why A2 Milk, Bravura, Magellan, and Pendal shares are dropping
- Here are the top 10 ASX 200 shares today
- Why A2 Milk, New Hope, Perpetual, and Talga shares are charging higher
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/K3AuECP








